Anaptysbio Inc (ANAB) returns
Anaptysbio returns over 5 years
$1,000 invested in Anaptysbio five years ago was worth $2,201 at the close on October 30, 2026, with dividends reinvested: an average return of 17.1% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -3.9% | — | $960.61 | -0.9% |
| 3 months | -12.3% | — | $877.18 | +2.1% |
| Year to date | +49.4% | — | $1,494 | +11.7% |
| 1 year | +98.6% | — | $1,986 | +12.4% |
| 3 years | +339.2% | +63.8% | $4,392 | +88.5% |
| 5 years | +120.1% | +17.1% | $2,201 | +76.0% |
Anaptysbio return by calendar year
| Year | ANAB | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +49.4% | +11.7% | +37.7% |
| 2025 | +266.2% | +17.7% | +248.4% |
| 2024 | -38.2% | +24.9% | -63.1% |
| 2023 | -30.9% | +26.2% | -57.1% |
| 2022 | -10.8% | -18.2% | +7.4% |
| 2021 | +61.6% | +28.7% | +32.9% |
| 2020 | +32.3% | +18.4% | +13.9% |
| 2019 | -74.5% | +31.2% | -105.7% |
| 2018 | -36.7% | -4.6% | -32.1% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: ANAB financials
No forecast, no recommendation. This page describes Anaptysbio Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.